Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk  | Very High  | Very High  | 
Rating  | 4.0  | 2.0  | 
Min SIP Amount  | ₹100  | ₹500  | 
Expense Ratio  | 1.54  | 1.85  | 
NAV  | ₹143.88  | ₹26.43  | 
Fund Started  | 11 Feb 2008  | 02 Dec 2020  | 
Fund Size  | ₹36827.67 Cr  | ₹4669.44 Cr  | 
Exit Load  | Exit load of 1% if redeemed within 1 year  | Exit load of 1% if redeemed within one year.  | 
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year  | 2.98%  | 1.38%  | 
3 Year  | 23.07%  | 18.66%  | 
5 Year  | 30.67%  | -  | 
1 Year
3 Year
5 Year
Equity  | 89.81%  | 96.34%  | 
Cash  | 10.19%  | 3.64%  | 
Equity
Cash
Top 10 Holdings  | 
  | 
  | 
Top 10 Holdings
Name  | Assets  | 
|---|---|
Firstsource Solutions Ltd.  | 4.90%  | 
Aster DM Healthcare Ltd.  | 4.11%  | 
eClerx Services Ltd.  | 4.02%  | 
Bank Of Baroda  | 3.29%  | 
Gabriel India Ltd.  | 3.17%  | 
Eris Lifesciences Ltd.  | 2.73%  | 
Fortis Healthcare Ltd.  | 2.65%  | 
Krishna Institute of Medical Sciences Ltd  | 2.12%  | 
Sudarshan Chemical Industries Ltd.  | 2.10%  | 
Indian Bank  | 1.97%  | 
Name  | Assets  | 
|---|---|
Multi Commodity Exchange Of India Ltd.  | 2.99%  | 
Karur Vysya Bank Ltd.  | 2.25%  | 
City Union Bank Ltd.  | 2.25%  | 
Aster DM Healthcare Ltd.  | 2.18%  | 
Affle 3I Ltd.  | 2.06%  | 
Navin Fluorine International Ltd.  | 1.99%  | 
Kei Industries Ltd.  | 1.98%  | 
Subros Ltd.  | 1.87%  | 
TD Power Systems Ltd.  | 1.84%  | 
Eris Lifesciences Ltd.  | 1.83%  | 
Name  | Chirag Setalvad  | Nitin Jain  | 
Start Date  | 28 Jun 2014  | 01 Oct 2024  | 
Name
Start Date
Description  | The scheme seeks to provide long-term capital appreciation /income by investing predominantly in Small-Cap companies.  | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of small cap companies.  | 
Launch Date  | 11 Feb 2008  | 02 Dec 2020  | 
Description
Launch Date